Medical Breakthrough: New Skin Cancer Therapy Tested in Australia


Melanoma is the most serious kind of skin cancer that develops in cells containing melanin pigment. According to data for 2015, over 3 million people around the world are diagnosed with the condition. 

In a recent attempt to treat the disease, Australian researchers conducted two separate trials to fight off the spread of the disease in patients whose tumors were surgically removed. 

The team announced the new therapy in a study published in the New England Journal of Medicine.

In an interview with Radio Sputnik, Dr. Andrew Haydon, a consultant with Alfred Hospital in Melbourne, explained how the new treatment is a breakthrough in treating the disease.

“These trials were conducted for treatment of stage three of melanoma following complete resection of metastasis in the lymph nodes. The aim of this treatment is to try and prevent further metastasis from spreading to stage four,” Haydon said.

According to the consultant, the first test was based on immunotherapy and required participants to take immunotherapy drugs for a year. In the second trial, the participants received a combination of targeted therapies, which block a melanoma-causing gene.

Both tests lasted one year, respectively, and their results have shown a considerable decrease in the chance of melanoma recurrence.

“There was a 20 percent reduction in the risk of relapse, which also resulted in a significant overall improvement in survival,” Haydon said.

According to the consultant, melanoma is the fifth most common cancer in Australia and it is the most common type of cancer in people under the age of 40. Hence, it is a very significant problem in the country.

“Australia has the highest rates of melanoma in the world,” Haydon said.

Talking about the availability of the drug and its price, Haydon said that the treatment is expensive, and one year costs about $50,000 to $80,000. It is, however, available in many countries and is approved for stage four cancer treatments.

Currently, the researchers are waiting for funding from the Australian government in order to make it more widely available for patients suffering from stage three melanoma.

© Flickr/ ZEISS Microscopy

Sputnik News

South Africa Today – World News – Asia and Pacific

Related Post

Chinese Enterprises Invest $835 Million on Adverti... This figure accounts for nearly 35 percent of total sponsorship deals signed for this year’s quadrennial football competition. Zenith said that the 2...
Reaper Drones to Surveil Afghanistan Under New Pen... Contract personnel with General Atomics will fly and maintain the drones in support of a US Marine Corps unit. They'll be used for reconnaissance, su...
'Fat Leonard' Scandal Mastermind Faces P... New Delhi (Sputnik) — A 57-year-old Singaporean citizen of Indian origin, Sharon Rachael Gursharan Kaur is likely to face a jail term of more than th...
Woman Slips Into 500ft Gorge While Taking Selfie i... New Delhi (Sputnik) – A woman vacationing with her family in Matheran, a popular hill station near India's financial capital Mumbai, fell into a 500-...
Disclaimer: The views of authors published on South Africa Today are their own and do not necessarily represent the views of South Africa Today. By viewing, visiting, using, or interacting with, you are agreeing to all the provisions of the Terms of Use Policy and the Privacy Policy.